Search results

Defence requirements push your technology, we can help. ANSTO is home to some of Australia’s most important landmark research infrastructure – more than $1.3bn of it.  Our unique capabilities are used by thousands of Australian researchers from industry and academia every year.

ANSTO's Minerals team provides consultancy, process development and research services to the mining and minerals processing industries.

ANSTO is seeking nominations for the ANSTO Australian Synchrotron Stephen Wilkins Thesis Medal.

The Detection & Imaging group builds on ANSTO’s 70-year history of scientific achievements and contributions in meeting the nuclear needs of industry, globally.

The High Performance Macromolecular Crystallography beamline will enable the study of very small (sub-5 micrometre) or weakly diffracting crystals, providing a state-of-the-art high-throughput facility for researchers. MX3 will be able to study the structures of large proteins and protein complexes for virology, drug design and industrial applications via goniometer mounted crystals, in-tray screening, or via serial crystallography methods.

Using the past to illuminate the future: Brothers collaborate on important science documentary for ABC TV

The final report on the safety of Building 23 by the independent expert review team has been completed.

View the upcoming proposal deadlines for access to ANSTO’s Research Portal. The User Office provides support for research proposals and enables you to leverage our world-class research infrastructure and facilities.

The ANSTO Science Series is a live and virtual meet-up that focuses on the key capacities of ANSTO’s people, partners and facilities and how they are meeting global challenges in sustainable industries, medicine, advanced manufacturing and in accelerating small business.

At ANSTO we understand that diverse teams produce better outcomes – and we value the merit that a diverse perspective can bring to the quality and outcomes of our work, and the way we get the job done.

ANSTO to receive a new grant to continue to fight chronic kidney disease killer in Sri Lanka.